GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Auro Laboratories Ltd (BOM:530233) » Definitions » Net Margin %

Auro Laboratories (BOM:530233) Net Margin % : 8.98% (As of Mar. 2025)


View and export this data going back to 2000. Start your Free Trial

What is Auro Laboratories Net Margin %?

Net margin is calculated as Net Income divided by its Revenue. Auro Laboratories's Net Income for the three months ended in Mar. 2025 was ₹6.8 Mil. Auro Laboratories's Revenue for the three months ended in Mar. 2025 was ₹75.4 Mil. Therefore, Auro Laboratories's net margin for the quarter that ended in Mar. 2025 was 8.98%.

The historical rank and industry rank for Auro Laboratories's Net Margin % or its related term are showing as below:

BOM:530233' s Net Margin % Range Over the Past 10 Years
Min: 2.37   Med: 9.13   Max: 14.53
Current: 9.47


BOM:530233's Net Margin % is ranked better than
64.32% of 967 companies
in the Drug Manufacturers industry
Industry Median: 4.93 vs BOM:530233: 9.47

Auro Laboratories Net Margin % Historical Data

The historical data trend for Auro Laboratories's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Auro Laboratories Net Margin % Chart

Auro Laboratories Annual Data
Trend Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25
Net Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 13.56 5.64 4.67 14.53 9.48

Auro Laboratories Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Net Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 19.75 13.16 11.55 1.67 8.98

Competitive Comparison of Auro Laboratories's Net Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, Auro Laboratories's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Auro Laboratories's Net Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Auro Laboratories's Net Margin % distribution charts can be found below:

* The bar in red indicates where Auro Laboratories's Net Margin % falls into.


;
;

Auro Laboratories Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

Auro Laboratories's Net Margin for the fiscal year that ended in Mar. 2025 is calculated as

Net Margin=Net Income (A: Mar. 2025 )/Revenue (A: Mar. 2025 )
=18.388/193.984
=9.48 %

Auro Laboratories's Net Margin for the quarter that ended in Mar. 2025 is calculated as

Net Margin=Net Income (Q: Mar. 2025 )/Revenue (Q: Mar. 2025 )
=6.771/75.402
=8.98 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Auro Laboratories  (BOM:530233) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.


Auro Laboratories Net Margin % Related Terms

Thank you for viewing the detailed overview of Auro Laboratories's Net Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Auro Laboratories Business Description

Traded in Other Exchanges
N/A
Address
S.K. Ahire Marg, 314, 3rd Floor, T.V. Industrial Estate, Worli, Mumbai, MH, IND, 400 030
Auro Laboratories Ltd is an India-based pharmaceutical company. It is engaged in the manufacturing and selling of pharmaceutical products like Metformin Hydrochloride and Glibenclamide. The pharmaceutical products range offered by the company are anti-diabetic, muscle relaxant, diuretic, iron deficiency anti-fungal, anti-ulcer, iodine supplement, anti-malaria, antacids, anti-inflammatory, specialty chemicals, and others. The company sells its products in India and also exports it to international countries.

Auro Laboratories Headlines

No Headlines